M&A Deal Summary

Stryker Acquires Concentric Medical

On August 31, 2011, Stryker acquired healthcare services company Concentric Medical for 135M USD

Acquisition Highlights
  • This is Stryker’s 4th transaction in the Healthcare Services sector.
  • This is Stryker’s 21st largest (disclosed) transaction.
  • This is Stryker’s 11th transaction in the United States.
  • This is Stryker’s 1st transaction in California.

M&A Deal Summary
Date 2011-08-31
Target Concentric Medical
Sector Healthcare Services
Buyer(s) Stryker
Deal Type Add-on Acquisition
Deal Value 135M USD
Advisor(s) J.P. Morgan Securities (Financial)

Target

Concentric Medical

Mountain View, California, United States
website
Concentric Medical, Inc., is a global leader in acute ischemic stroke intervention.

Search 193,381 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Stryker

Kalamazoo, Michigan, United States

website

Category Company
Founded 1941
Sector Medical Products
Employees51,000
Revenue 18.4B USD (2022)
DESCRIPTION
Stryker's corporate headquarters in Kalamazoo, Michigan.
Stryker's corporate headquarters in Kalamazoo, Michigan.

Stryker is a medical technology company. Stryker's products include implants used in joint replacement and trauma surgeries; surgical equipment and surgical navigation systems; endoscopic and communications systems; patient handling and emergency medical equipment; neurosurgical, neurovascular and spinal devices; as well as other medical device products used in a variety of medical specialties. Stryker was founded in 1941 and is based in Kalamazoo, Michigan.

DEAL STATS #
Overall 12 of 45
Sector (Healthcare Services) 4 of 6
Type (Add-on Acquisition) 8 of 39
State (California) 1 of 7
Country (United States) 11 of 30
Year (2011) 4 of 4
Size (of disclosed) 21 of 23
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2011-07-06 Memometal Technologies S.A.

Bruz, France

Memometal is an international designer and manufacturer of surgical implants for orthopaedic extremities. While working directly with specialist surgeons, Memometal designs products aimed at their success : Memometal implants are reliable while surgical techniques are simple and reproducible. Throughout product development, Memometal has as its main purpose of creating implants that improve the comfort level and the safety of patients.

Buy $150M
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2012-11-01 Surpass Medical

Tel-Aviv, Israel

Surpass Medical, Ltd. (Surpass). Surpass is developing and commercializing the NeuroEndoGraft family of next-generation flow diversion stent technology to treat brain aneurysms using a unique mesh design and delivery system.

Buy $135M
Mergr

Product

Company

Legal